FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
FDA General

Hahn and CDCs Redfield Dismiss Deep State Concerns

FDA commissioner Stephen Hahn and CDC director Robert Redfield dismiss notions that a deep state operates within their agencies intent on damaging pre...

Human Drugs

CGMP Violations at HNC Products

FDA warns HNC products about significant violations of CGMP regulations in its production of OTC drugs.

FDA General

Continuous Manufacturing and Counterfeit Devices Bills Pass

The U.S. House passes two bills having wide implications for FDA in supporting Continuous Pharmaceutical Manufacturing and combating counterfeit medic...

Federal Register

Final Rule Correction on Animal Drug e-Submission

Federal Register notice: FDA corrects a 7/29 final rule requiring electronic submission of certain postmarketing safety reports for approved new anima...

Human Drugs

Minor CRL for Hikmas Generic Advair Diskus

Hikma says it expects final FDA approval of its ANDA for a generic form of GSKs Advair Diskus early next year.

Human Drugs

FDA Priority Review for BMS Ide-Cel

FDA says it will give priority review to a BLA submitted by Bristol-Myers Squibb and bluebird bio for their ide-cel, the first CAR T cell therapy acce...

Medical Devices

FDA Launches Digital Health Center of Excellence

FDA says it is launching a Digital Health Center of Excellence within CDRH.

Human Drugs

Coupler Enterprises CGMP Inspection Violations

FDA warns Coupler Enterprises about CGMP violations in its manufacturing of finished drugs.

FDA Amending Medical Product Intended Use Regs

FDA says it will update regulations to clarify the types of evidence it considers when determining the intended use of a medical product.

Federal Register

Draft Guide on Cannabidiol Bioequivalence

Federal Register notice: FDA makes available a draft guidance entitled Draft Guidance for Cannabidiol.